Milan Laboratories (india) Private Limited — Flucloxacillin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Flucloxacillin · $1.8M export value · DGFT Verified
Milan Laboratories (india) Private Limited is the #4 Indian exporter of Flucloxacillin with $1.8M in export value and 29 verified shipments. Milan Laboratories (india) Private Limited holds a 3.7% market share in Flucloxacillin exports across 3 countries. The company exports 5 pharmaceutical products worth $4.6M across 5 therapeutic categories.
Milan Laboratories (india) Private Limited — Flucloxacillin Export Profile: Buyers & Destinations
Where Does Milan Laboratories (india) Private Limited Export Flucloxacillin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $949.2K | 29 | 69.7% |
| UNITED KINGDOM | $362.1K | 8 | 26.6% |
| FIJI | $50.0K | 1 | 3.7% |
Milan Laboratories (india) Private Limited exports Flucloxacillin to 3 countries. The largest destination is SOUTH AFRICA accounting for 69.7% of Milan Laboratories (india) Private Limited's Flucloxacillin shipments, followed by UNITED KINGDOM (26.6%) and FIJI (3.7%). These destinations reflect Milan Laboratories (india) Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Flucloxacillin from Milan Laboratories (india) Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | SOUTH AFRICA | $361.0K | 8 |
| TO THE ORDER OF... | SOUTH AFRICA | $314.5K | 14 |
| NOUMED LIFESCIENCE LTD | UNITED KINGDOM | $262.1K | 6 |
| OETHMAAN BIOSIMS (PTY) LTD | SOUTH AFRICA | $173.7K | 4 |
| OETHMAAN BIOSIMS PTY LTD | SOUTH AFRICA | $100.0K | 2 |
| TO THE ORDER. | UNITED KINGDOM | $100.0K | 2 |
| TO THE ORDER OF.,.,., | FIJI | $50.0K | 1 |
| TO THE ORDER OF | SOUTH AFRICA | $0 | 1 |
Milan Laboratories (india) Private Limited supplies Flucloxacillin to 8 buyers globally. The largest buyer is TO THE ORDER (SOUTH AFRICA), followed by TO THE ORDER OF... (SOUTH AFRICA) and NOUMED LIFESCIENCE LTD (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Flucloxacillin Export Value and How Much Does Milan Laboratories (india) Private Limited Contribute?
India exported $30.0M worth of Flucloxacillin through 1,146 shipments from 123 suppliers to 44 countries, serving 198 buyers globally. Milan Laboratories (india) Private Limited contributes $1.8M to this total, accounting for 3.7% of India's Flucloxacillin exports. Milan Laboratories (india) Private Limited ships Flucloxacillin to 3 countries through 8 buyers.
What Is the Average Shipment Value for Milan Laboratories (india) Private Limited's Flucloxacillin Exports?
Milan Laboratories (india) Private Limited's average Flucloxacillin shipment value is $62.1K per consignment, based on 29 shipments totaling $1.8M. The largest destination is SOUTH AFRICA (69.7% of Milan Laboratories (india) Private Limited's Flucloxacillin exports).
How Does Milan Laboratories (india) Private Limited Compare to Other Indian Flucloxacillin Exporters?
Milan Laboratories (india) Private Limited ranks #4 among 123 Indian Flucloxacillin exporters with a 3.7% market share. The top 3 exporters are MEDREICH LIMITED ($16.9M), MICRO LABS LIMITED ($4.0M), AUROBINDO PHARMA LTD ($1.7M). Milan Laboratories (india) Private Limited processed 29 shipments to 3 destination countries.
What Flucloxacillin Formulations Does Milan Laboratories (india) Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL GOODS HARMLESS MEDICINES FLUCLOXACILLIN 500 MG CAPSULES 67397X2X14CAP 1887116 OTHER DETAILS AS PER INV | $50.0K | 1 |
| PHARMACEUTICAL GOODS HARMLESS MEDICINES FLUCLOXACILLIN 500 MG CAPSULES 44214X2X14CAP 1237992 OTHER DETAILS AS PER INV | $50.0K | 1 |
| PHARMACEUTICAL GOODS HARMLESS MEDICINES FLUCLOXACILLIN 500 MG CAPSULES 88960X2X14CAP 2490880 OTHER DETAILS AS PER INV | $50.0K | 1 |
| PHARMA GOODS HARMLESS MEDICINES FLUCLOXACILLIN 250 MG CAPSULES 61698PACx2 X 14 1727544CAPS CONTAINS AS PER INVOICE | $50.0K | 1 |
| PHARMA. GOODS/HARMLESS MEDICINE:Flucloxacillin 250mg Oethmaan122805PACx1X20=2456100CAPSEACH CAP CONT:AS PER DOCUMENT | $50.0K | 1 |
| PHARMA. GOODS/HARMLESS MEDICINE:Flucloxacillin 250mg Oethmaan122810PACx1X40=4912400CAPSEACH CAP CONT:AS PER DOCUMENT | $50.0K | 1 |
| PHARMACEUTICAL GOODS/HARMLESS MEDICINESFlucloxacillin 250mg Oethmaan [123605x1x20=2472100 caps]Each capsule cont:as per | $50.0K | 1 |
| PHARMA.GOODS/HARMLESS MEDICINE:FLUCLOXACILLIN 250MG OETHMAAN[98160X1X40=3926400CAPS]EACH CAPSULE CONTAINS:AS PER INVOIC | $50.0K | 1 |
| PHARMA.GOODS/HARMLESS MEDICINE:FLUCLOXACILLIN 250MG OETHMAAN (123705PACX1X20=2474100 CAPS) CONT AS PER INVOICE | $50.0K | 1 |
| PHARMA.GOODS/HARMLESS MEDICINE:FLUCLOXACILLIN 250MG OETHMAAN (61405PACX1X40=2456200 CAPS) CONT AS PER INVOICE | $50.0K | 1 |
Milan Laboratories (india) Private Limited exports 37 distinct Flucloxacillin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL GOODS HARMLESS MEDICINES FLUCLOXACILLIN 500 M with 1 shipments worth $50.0K.
Regulatory Requirements: Exporting Flucloxacillin to Key Markets
What Milan Laboratories (india) Private Limited must comply with to export Flucloxacillin to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Milan Laboratories (india) Private Limited Compare to Nearest Flucloxacillin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MICRO LABS LIMITED | $4.0M | 81 | 2 | $50.0K |
| 5 | AUROBINDO PHARMA LTD | $1.7M | 43 | 1 | $39.3K |
| 4 | MILAN LABORATORIES (INDIA) PRIVATE LIMITED ★ | $1.4M | 29 | 3 | $50.0K |
| 6 | KOPRAN LIMITED | $1.3M | 26 | 2 | $50.0K |
| 7 | AJANTA PHARMA LIMITED | $860.1K | 76 | 5 | $11.3K |
Milan Laboratories (india) Private Limited ranks #4 among 123 Indian Flucloxacillin exporters. Average shipment value of $50.0K compared to the market average of $243.5K. The closest competitors by value are MICRO LABS LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Flucloxacillin Exports?
| Port | Shipments | % Share |
|---|---|---|
| BANGALORE ICD | 140 | 12.2% |
| BANGALORE ICD (INWFD6) | 107 | 9.3% |
| NHAVA SHEVA SEA (INNSA1) | 100 | 8.7% |
| JNPT | 76 | 6.6% |
| BANGALORE ACC (INBLR4) | 69 | 6.0% |
| JNPT/ NHAVA SHEVA SEA | 55 | 4.8% |
| SAHAR AIR | 50 | 4.4% |
| BANGALORE AIR | 36 | 3.1% |
About Milan Laboratories (india) Private Limited
Milan Laboratories (india) Private Limited exports 5 products worth $4.6M. Beyond Flucloxacillin, top products include Clotrimazole, Rivaroxaban, Clonazepam, Quinine. View the complete Milan Laboratories (india) Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Flucloxacillin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Flucloxacillin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Milan Laboratories (india) Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 38 individual customs records matching Milan Laboratories (india) Private Limited exporting Flucloxacillin, covering 37 formulations to 3 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 44+ countries, 198+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Flucloxacillin Export Data from Milan Laboratories (india) Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Milan Laboratories (india) Private Limited's Flucloxacillin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Milan Laboratories (india) Private Limited
Full Company Profile →
5 products · $4.6M total trade · 5 categories
Flucloxacillin Stats
Company Overview
Top Products by Milan Laboratories (india) Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Milan Laboratories (india) Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Flucloxacillin. For current shipment-level data, contact TransData Nexus.